Clinical trial
The Effects of Immunomodulatory Therapy in Patients with Vasospastic Angina
NCT06696807 is registered in ClinicalTrials.gov with Dao Wen Wang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Immunomodulatory Therapy in Patients with Vasospastic Angina
- Lead sponsor
- Dao Wen Wang
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- May 1, 2024
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vasospastic angina